Increase in the circulating level of hepatocyte growth factor in gastric cancer patients

British Journal of Cancer

Volumn 75, Issue 5, 1997, Pages 673-677

  Taniguchi, T ^a   Kitamura, M ^a   Arai, K ^a   Iwasaki, Y ^a   Yamamoto, Y ^a   Igari, A ^a   Toi, M ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

CA125; CA19 9; CEA; Gastric cancer; Hepatocyte growth factor; Tumour marker

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; SCATTER FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER INVASION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT CANCER; STOMACH CANCER;

EID: 0031055241     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.120     Document Type: Article

References (25)

1. Dignass AU, Lynch-Devaney K and Podolsky DK (1994) Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 202: 701-709
2. Eagles G, Warn A, Ball RY, Baillie-Johnson H, Arakaki N, Daikuhara Y and Warn RM (1996) Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. Br J Cancer 76: 377-381
3. DI Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P and Comoglio PM (1991) Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6: 1997-2003
4. Foekens JA, Look MP, Peters HA, Van Putten WLJ, Portengen, H and Klijin, JGM (1995) Urokinase-type plasminogen activator and its inhibitor PAI-I: predictors of poor response to tamoxifen therapy in recurrent breast cancer. J Nat Cancer Inst 87: 751-755
5. Fuller SA, Takahashi M and Hurrell JGR (1987) Preperation of monoclonal antibodies. In Current Protocols in Molecular Biology, Ausubel F, Brent B, Kingston R, Noore DD, Seidman JG, Smith JA and Struhl K (eds). 11.4.1-11.4.5 Greene Publishing: New York.
6. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P and Rosen EM (1993) Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937-1941
7. Guadagni F, Roselli M, Amato T, Cosimelli M, Perri P, Casale V, Carlini M, Santoro E, Cavaliere R and Greiner JW (1992) CA 72-4 measurement of tumor-associated glycoprotein 72(TAG-72) as a serum marker in the management of gastric carcinoma. Cancer Res 52: 1222-1227
8. Hildenbrand R, Dilger I, Horlin A and Stutte HJ (1995) Urokinase and macrophages in tumor angiogenesis. Br J Cancer 72: 818-823
9. Kondo S, Shinomura Y, Kanayama S, Higashimoto Y, Kiyohara T, Yasunaga Y, Kitamura S, Ueyama H, Imamura I, Fukui H and Matsuzawa Y (1995) Helicobacter pylori increases gene expression of hepatocyte growth factor in human gastric mucosa. Biochem Biophys Res Commun 210: 960-965
10. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H and Tahara E (1992) Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 189: 227-232
11. Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y and Tahara E (1993) Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Cancer 55: 72-75
12. Ming SC (1977) Gastric carcinoma, A pathological classification. Cancer 39: 2475-2485
13. Naka D, Ishii T and Shimomura T (1993) Haparin modulates the receptor-binding and mitogen activity of hepatocyte growth factor on hepatocytes. Exp Cell Res 209: 317-324
14. Nakamura T, Nawa K and Ichihara A (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats. Biochem Biophys Res Commun 122: 1450-1459
15. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F and Comoglio, PM (1992) Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11: 4825-4833
16. Naldini L, Vigna E, Badelli A, Follenzi A, Galimi F and Comoglio PM (1995) Biological activation of pro-HGF (hepatosyte growth factor) by urokinase is controlled by a stoichiometric reaction. J Biol Biochem 270: 603-611
17. Rosen EM, Carley W and Goldberg LD (1990) Scatter factor regulates vascular endothelial cell motility. Cancer Invest 8: 647-650
18. Seslar S, Nakamura T and Byers S (1995) Tumor-stroma interactions and stromal cell density regulate hepatocyte growth factor protein levels: a role for transforming growth factor-beta activation. Endocrinology 136: 1945-1953
19. Tajima H, Matsumoto K and Nakamura T (1992) Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 202: 423-431
20. Tamura M, Arakaki N, Tsubouchi H and Daikuhara Y (1993) Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J Biol Chem 268: 8140-8145
21. Taniguchi T, Toi M and Tominaga T (1994) Rapid induction of hepatocyte growth factor by heparin. Lancet 344: 470
22. Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y and Tominaga T (1995) Serum Concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1: 1031-1034
23. Yamada A, Matsumoto K, Iwanari H, Sekiguchi K, Kawata S, Matsuzawa Y and Nakamura T (1995) Rapid and sensitive enzyme-linked immunosorbent assey for measurement or HGF in rat and human tissues. Biochem Res 16: 105-114
24. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishji T and Shin S (1994) Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54: 1630-1633
25. Wobbes T, Thomas CM, Seger MF and Nagengast FM (1992) Evaluation of seven tumor markers (CA50, CA19-9, CA19-9 TruQuant, CA72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma. Cancer 69: 2036-2041